Vestal Point Capital, LP Portfolio Holdings

Vestal Point Capital, LP

  • $1.9 Trillion
  • Q2 2025

Vestal Point Capital, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $1.9 Trillion distributed in 72 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $181B, Jazz Pharmaceuticals PLC with a value of $127B, Cytokinetics Inc with a value of $98.3B, Nuvalent, Inc. with a value of $82B, and Vera Therapeutics, Inc. with a value of $73B.

Examining the 13F form we can see an increase of $499B in the current position value, from $1.4T to 1.9T.

Vestal Point Capital, LP is based out at New York, NY

Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.9 Trillion
Healthcare: $251 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 72
  • Current Value $1.9 Trillion
  • Prior Value $1.4 Trillion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 22 stocks
  • Additional Purchases 26 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email